ArticleEuropean journal of clinical pharmacology2018

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects.

Anne Gardin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.